Jacobs Levy Equity Management, Inc Halozyme Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$16.25 - $26.81 $3.23 Million - $5.33 Million	-198,772 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $295,375 - $463,887	21,250 Added 11.97%	198,772 $3.58 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $4.65 Million - $6.08 Million	-311,480 Reduced 63.7%	177,522 $3.15 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $617,059 - $718,143	-40,596 Reduced 7.67%	489,002 $7.58 Million
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $1.01 Million - $1.18 Million	68,420 Added 14.84%	529,598 $9.1 Million
Q1 2019 May 14, 2019	BUY	$13.94 - $17.58 $1.86 Million - $2.35 Million	133,700 Added 40.83%	461,178 $7.43 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $313,255 - $438,510	-23,500 Reduced 6.7%	327,478 $4.79 Million
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $639,644 - $705,986	38,348 Added 12.27%	350,978 $6.38 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $976,604 - $1.18 Million	57,890 Added 22.73%	312,630 $5.27 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $3.12 Million - $3.87 Million	182,630 Added 253.27%	254,740 $4.99 Million
Q4 2017 Feb 13, 2018	BUY	$16.75 - $20.8 $599,650 - $744,640	35,800 Added 98.6%	72,110 $1.46 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $427,005 - $631,794	36,310	36,310 $631,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.